ADAGIO THERAPEUTICS INC (ADGI)
US00534A1025 - Common Stock
ChartMill assigns a Buy % Consensus number of 47% to ADGI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.91. This target is -15.73% below the current price.
ADGI was analyzed by 9 analysts. The buy percentage consensus is at 47. So analysts seem to be rather neutral about ADGI.
In the previous month the buy percentage consensus was at a similar level.
ADGI was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-17 | Morgan Stanley | Maintains | Underweight |
| 2022-01-06 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2021-12-22 | Jefferies | Downgrade | Buy -> Hold |
| 2021-12-15 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-12-15 | Stifel | Downgrade | Buy -> Hold |
| 2021-12-15 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-11-29 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2021-08-31 | Guggenheim | Initiate | Buy |
| 2021-08-31 | Stifel | Initiate | Buy |
| 2021-08-31 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-08-31 | Jefferies | Initiate | Buy |